NDC 0006-0267

MAXALT

Rizatriptan Benzoate

MAXALT is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Rizatriptan Benzoate.

Product ID0006-0267_26ec70b6-95bf-4efa-a907-cc605943d08f
NDC0006-0267
Product TypeHuman Prescription Drug
Proprietary NameMAXALT
Generic NameRizatriptan Benzoate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1998-06-29
Marketing CategoryNDA / NDA
Application NumberNDA020864
Labeler NameMerck Sharp & Dohme Corp.
Substance NameRIZATRIPTAN BENZOATE
Active Ingredient Strength10 mg/1
Pharm ClassesSerotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0006-0267-18

18 POUCH in 1 CARTON (0006-0267-18) > 1 TABLET in 1 POUCH (0006-0267-01)
Marketing Start Date1998-06-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0006-0267-18 [00006026718]

MAXALT TABLET
Marketing CategoryNDA
Application NumberNDA020864
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1998-06-29

NDC 0006-0267-12 [00006026712]

MAXALT TABLET
Marketing CategoryNDA
Application NumberNDA020864
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1998-06-29
Marketing End Date2012-08-31

NDC 0006-0267-01 [00006026701]

MAXALT TABLET
Marketing CategoryNDA
Application NumberNDA020864
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-08-17

Drug Details

Active Ingredients

IngredientStrength
RIZATRIPTAN BENZOATE10 mg/1

OpenFDA Data

SPL SET ID:d93286f5-99f7-4dc5-aa9d-ad73ab8490db
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213321
  • 213322
  • 314209
  • 828536
  • 312837
  • 828537
  • 312840
  • 312839

    • Pharmacological Class

    • Serotonin 1b Receptor Agonists [MoA]
    • Serotonin 1d Receptor Agonists [MoA]
    • Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

    NDC Crossover Matching brand name "MAXALT" or generic name "Rizatriptan Benzoate"

    NDCBrand NameGeneric Name
    0006-0266MAXALTrizatriptan benzoate
    0006-0267MAXALTrizatriptan benzoate
    21695-956MAXALTrizatriptan benzoate
    0006-3800MAXALT-MLTrizatriptan benzoate
    0006-3801MAXALT-MLTrizatriptan benzoate
    0093-7471Rizatriptan BenzoateRizatriptan Benzoate
    0093-7472Rizatriptan BenzoateRizatriptan Benzoate
    0378-1403Rizatriptan Benzoaterizatriptan benzoate
    0378-1404Rizatriptan Benzoaterizatriptan benzoate
    0378-3701Rizatriptan Benzoaterizatriptan benzoate
    0378-3702Rizatriptan Benzoaterizatriptan benzoate
    0781-5425Rizatriptan Benzoaterizatriptan benzoate
    0781-5426Rizatriptan Benzoaterizatriptan benzoate
    0781-5485Rizatriptan benzoateRizatriptan benzoate
    0781-5486Rizatriptan benzoateRizatriptan benzoate
    23155-244Rizatriptan BenzoateRizatriptan Benzoate
    23155-245Rizatriptan BenzoateRizatriptan Benzoate
    29300-268Rizatriptan BenzoateRizatriptan Benzoate
    29300-269Rizatriptan BenzoateRizatriptan Benzoate
    29300-316Rizatriptan BenzoateRizatriptan Benzoate
    29300-317Rizatriptan BenzoateRizatriptan Benzoate

    Trademark Results [MAXALT]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    MAXALT
    MAXALT
    75044802 2053617 Live/Registered
    MERCK SHARP & DOHME CORP.
    1996-01-17
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.